Log in | Register

Adjuvant therapy in acute heart failure

Tahar Chouihed| Alexa Hollinger| Alexandre Mebazaa
What's New in Intensive Care
Volume 44, Issue 6 / June , 2018

Pages 900 - 903

No abstract available.

References

  1. Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G et al (2016) Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med 42(2):147–163
  2. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S et al (2015) Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency. Eur J Heart Fail 17(6):544–558
    • View reference on publisher's website
    • View reference on PubMed
  3. Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S et al (2017) Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 69(25):3042–3051
    • View reference on publisher's website
    • View reference on PubMed
  4. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797–805
    • View reference on publisher's website
    • View reference on PubMed
  5. ter Maaten JM, Valente MAE, Damman K, Hillege HL, Navis G, Voors AA (2015) Diuretic response in acute heart failure—pathophysiology, evaluation, and therapy. Nat Rev Cardiol 12(3):184–192
    • View reference on publisher's website
    • View reference on PubMed
  6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200
    • View reference on publisher's website
    • View reference on PubMed
  7. Masip J, Roque M, Sánchez B, Fernández R, Subirana M, Expósito JA (2005) Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA 294(24):3124–3130
    • View reference on publisher's website
    • View reference on PubMed
  8. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377
  9. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al (2017) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. https://doi.org/10.1093/eurheartj/ehx393
    • View reference on PubMed
  10. Pirracchio R, Parenica J, Resche Rigon M, Chevret S, Spinar J, Jarkovsky J et al (2013) The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One 8(8):e71659
    • View reference on publisher's website
    • View reference on PubMed
  11. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C et al (2014) Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40(12):1795–1815
  12. Koster G, Bekema HJ, Wetterslev J, Gluud C, Keus F, van der Horst ICC (2016) Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 42(9):1322–1335
  13. Tarvasmäki T, Lassus J, Varpula M, Sionis A, Sund R, Køber L et al (2016) Current real-life use of vasopressors and inotropes in cardiogenic shock—adrenaline use is associated with excess organ injury and mortality. Crit Care 20(1):208
    • View reference on publisher's website
    • View reference on PubMed
  14. Harjola V-P, Mebazaa A, Čelutkienė J, Bettex D, Bueno H, Chioncel O et al (2016) Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 18(3):226–241
    • View reference on publisher's website
    • View reference on PubMed
  15. Levy B, Bastien O, Karim B, Cariou A, Chouihed T, Combes A et al (2015) Experts’ recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care 5(1):52. https://doi.org/10.1186/s13613-015-0063-y
    • View reference on publisher's website
    • View reference on PubMed
  16. Peacock WF, Emerman C, Costanzo MR, Diercks DB, Lopatin M, Fonarow GC (2009) Early vasoactive drugs improve heart failure outcomes. Congest Heart Fail 15(6):256–264
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement